Achyut Healthcare Welcomes Zenith Life Care as New Shareholder

Achyut Healthcare Limited has completed a preferential allotment of 2,00,000 equity shares to Zenith Life Care Private Limited. This transaction represents a 0.08% stake in the company and has increased Achyut Healthcare's total and diluted voting capital from approximately ₹23.56 crore to ₹24.14 crore.

The Transaction

Achyut Healthcare Limited announced on March 24, 2026, that Zenith Life Care Private Limited acquired 2,00,000 equity shares via a preferential allotment on March 23, 2026. This acquisition represents 0.08% of Achyut Healthcare's total and diluted voting capital. Following the allotment, the company's equity share capital has risen from ₹23.56 crore to ₹24.14 crore.

Why This Matters

The addition of Zenith Life Care Private Limited signifies a new investor joining Achyut Healthcare's shareholder base. While the stake is small, this capital infusion contributes to the company's overall equity base.

Company Background

Founded in 1996, Achyut Healthcare Limited began as a private entity before becoming a public limited company in November 2021. The company has been active in capital raising initiatives. Recently, Achyut Healthcare completed a stock split (₹10 to ₹1 face value) in December 2024 and has secured approval for its migration from the BSE SME platform to the Main Board of BSE. Prior to this, the company also undertook a preferential allotment of 58,00,000 shares in March 2026, raising ₹3.48 crore, and obtained in-principle BSE approval for preferential issues in early March 2026.

Immediate Changes

• Zenith Life Care Private Limited is now a registered shareholder in Achyut Healthcare Limited.
• The total paid-up equity share capital of Achyut Healthcare Limited has been enhanced.
• The ownership structure has seen a minor alteration with the introduction of a new, small stake.

Key Risks

• Achyut Healthcare operates in a highly competitive pharmaceutical market with numerous established players and new entrants.
• The company's performance may be influenced by evolving government policies, such as revised Drug Price Control Orders (DPCO).

Peer Landscape

Achyut Healthcare operates within the pharmaceutical sector. In peer comparisons, Achyut Healthcare has been identified as 'Overvalued' with a potential downside risk of 38.1% based on certain valuation metrics.

Next Steps for Investors

• Monitor any further stake acquisitions or changes by Zenith Life Care Private Limited.
• Observe Achyut Healthcare's financial performance and operational progress post-capital infusion.
• Track the company's ongoing migration process from the BSE SME platform to the Main Board.
• Assess the company's ability to navigate competitive pressures and regulatory changes.